Ovarian Cancer

A new DNA test can predict how long women with ovarian cancer will survive, and guide personalized treatment decisions, according to new research.

There currently are no established screening for ovarian cancer. A new screening strategy based on blood tests appears to be highly specific for detecting the disease before it becomes lethal.

Women without risk factors for ovarian cancer should not undergo screening tests for the disease, new recommendations say.

Recent research suggests a woman's fallopian tubes are the true source of some of the deadliest ovarian cancers, and removing them could lower her risk of developing the disease.

Women who take hormones to relieve symptoms of menopause could be increasing their risk of developing ovarian cancer no matter what type of hormones, according to new research.

Four newfound variations in a woman's genes increase her risk of developing ovarian cancer.

Women with ovarian cancer taking the diabetes drug metformin were more likely to survive five years than women not taking the drug, a new study finds.

Prevention strategies for ovarian cancer, a particularly deadly disease, are sorely needed, experts say.

The drug Avastin delayed the worsening of ovarian cancer by four months.